# Catheter Ablation Versus Antiarrhythmic Drugs for Outflow Tract Ventricular ARrhythmias

> **NCT01780311** · PHASE4 · UNKNOWN · sponsor: **Ospedale San Donato**

## Conditions studied

- Ventricular Tachycardia
- Ventricular Premature Complexes

## Interventions

- **DRUG:** antiarrhythmic drugs (Flecainide or Propafenone or Sotalol)
- **PROCEDURE:** Catheter Ablation

## Key facts

- **NCT ID:** NCT01780311
- **Lead sponsor:** Ospedale San Donato
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-01
- **Primary completion:** 2014-01
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01780311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01780311, "Catheter Ablation Versus Antiarrhythmic Drugs for Outflow Tract Ventricular ARrhythmias". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01780311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*